Key result
Percutaneous closure of an atrial septal defect using an Amplatzer Septal Occluder resulted in life-threatening late cardiac rupture and tamponade 79 days post-implantation in a 22-year-old woman.
Case Report (n=1)
Highlights the rare but life-threatening risk of late cardiac rupture following transcatheter closure of atrial septal defects.
Answers are grounded in this paper and cite their sources.
May warrant extended post-procedure surveillance after Amplatzer ASD closure; leaves open true incidence and device-specific risks.
Transcatheter device implantation has become an attractive alternative to surgery in the closure of atrial septal defects in selected patients. However, it can lead to early and late sequelae, some of them life threatening. For example, 79 days before her admission to our emergency department with sudden-onset respiratory distress and respiratory arrest (leading to cardiac tamponade and rupture), a 22-year-old woman had undergone percutaneous closure of an atrial septal defect. We describe the damage and its treatment. Although the adverse effects of transcatheter device implantation are rare, physicians should know that these events can be life threatening. Further data are needed to prevent such sequelae and to design new devices. It is of utmost importance that patients and their family members be informed both of possible sequelae and of life-saving interventions to be administered at early diagnosis.
No takes yet. Share an insight, caveat, or question.
Arnaz et al. (2016) conducted a case report in Atrial septal defect (n=1). Amplatzer Septal Occluder was evaluated. Percutaneous closure of an atrial septal defect using an Amplatzer Septal Occluder resulted in life-threatening late cardiac rupture and tamponade 79 days post-implantation in a 22-year-old woman.
Synapse has enriched 10 related papers. Consider them for comparative context: